# FDA Inspection 1031120 - Vitalant - November 02, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/582b6b3e-6bce-4816-8efd-a27a9fdb2e08
Source feed: FDA_Inspections

> FDA Inspection 1031120 for Vitalant on November 02, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031120
- Company Name: Vitalant
- Inspection Date: 2017-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1111190 - 2019-10-11](https://www.keypedia.com/records/fda_inspections/vitalant/77b97600-b3c6-4f60-87f0-f5ad45b027e6)
- [FDA Inspection 986640 - 2016-09-15](https://www.keypedia.com/records/fda_inspections/vitalant/1f740bf1-db25-4c45-aaf7-1f15d16c0b02)
- [FDA Inspection 813434 - 2013-01-09](https://www.keypedia.com/records/fda_inspections/vitalant/29b6b2c1-4632-42f4-be43-6b0fabb4ab7c)
- [FDA Inspection 747132 - 2011-09-28](https://www.keypedia.com/records/fda_inspections/vitalant/bb8dd682-faee-440d-8e7d-e8480029b374)
- [FDA Inspection 638564 - 2009-12-22](https://www.keypedia.com/records/fda_inspections/vitalant/ec458d8b-9fe0-4450-a5db-c2d1fc8f7f58)

Company: https://www.keypedia.com/companies/vitalant/4dd304af-337a-4be4-a1e1-4cda1d150c05

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d